Cargando…

Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications

Reconstituted high-density lipoproteins (rHDLs) can transport and specifically release drugs and imaging agents, mediated by the Scavenger Receptor Type B1 (SR-B1) present in a wide variety of tumor cells, providing convenient platforms for developing theranostic systems. Usually, phospholipids or A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aranda-Lara, Liliana, Isaac-Olivé, Keila, Ocampo-García, Blanca, Ferro-Flores, Guillermina, González-Romero, Carlos, Mercado-López, Alfredo, García-Marín, Rodrigo, Santos-Cuevas, Clara, Estrada, José A., Morales-Avila, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610567/ https://www.ncbi.nlm.nih.gov/pubmed/36296638 http://dx.doi.org/10.3390/molecules27207046

Ejemplares similares

(225)Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins
por: Hernández-Jiménez, Tania, et al.
Publicado: (2022)

rHDL modeling and the anchoring mechanism of LCAT activation
por: Laurenzi, Tommaso, et al.
Publicado: (2020)

Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma
por: Sabnis, Nirupama, et al.
Publicado: (2013)

Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020)

Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)

Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis
por: Fernández-de-Retana, Sofía, et al.
Publicado: (2017)

Cholesterol Determines and Limits rHDL Formation from Human Plasma Apolipoprotein A-II and Phospholipid Membranes
por: Bassett, G. Randall, et al.
Publicado: (2012)

Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34(+) Cells in Patients after an Acute Coronary Syndrome
por: Gebhard, Catherine, et al.
Publicado: (2017)

Fluorescent, Plasmonic, and Radiotherapeutic Properties of the (177)Lu–Dendrimer-AuNP–Folate–Bombesin Nanoprobe Located Inside Cancer Cells
por: Mendoza-Nava, Héctor, et al.
Publicado: (2017)

Photoactivation of Chemotherapeutic Agents with Cerenkov Radiation for Chemo-Photodynamic Therapy
por: Gallaga-González, Uriel, et al.
Publicado: (2022)

Synthesis and Evaluation of (177)Lu-DOTA-DN(PTX)-BN for Selective and Concomitant Radio and Drug—Therapeutic Effect on Breast Cancer Cells
por: Gibbens-Bandala, Brenda, et al.
Publicado: (2019)

Cuban Sugar Cane Wax Alcohol Exhibited Enhanced Antioxidant, Anti-Glycation and Anti-Inflammatory Activity in Reconstituted High-Density Lipoprotein (rHDL) with Improved Structural and Functional Correlations: Comparison of Various Policosanols
por: Cho, Kyung-Hyun, et al.
Publicado: (2023)

Ganglioside GM3-Functionalized Reconstituted High-Density Lipoprotein (GM3-rHDL) as a Novel Nanocarrier Enhances Antiatherosclerotic Efficacy of Statins in apoE(−/−) C57BL/6 Mice
por: Wei, Bo, et al.
Publicado: (2022)

Hybrid (2D/3D) Dosimetry of Radiolabeled Gold Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer
por: Ramírez-Nava, Gerardo, et al.
Publicado: (2020)

Toxicity Assessment of [(177)Lu]Lu−iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes
por: Hernández-Jiménez, Tania, et al.
Publicado: (2022)

Controlled-Release Nanosystems with a Dual Function of Targeted Therapy and Radiotherapy in Colorectal Cancer
por: Cruz-Nova, Pedro, et al.
Publicado: (2022)

[(99m)Tc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients
por: Coria-Domínguez, Luis, et al.
Publicado: (2022)

[(99m)Tc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities
por: Vallejo-Armenta, Paola, et al.
Publicado: (2022)

Development of (177)Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen
por: Carpanese, Debora, et al.
Publicado: (2020)

Synthesis and Evaluation of (177)Lu-DOTA-PD-L1-i and (225)Ac-HEHA-PD-L1-i as Potential Radiopharmaceuticals for Tumor Microenvironment-Targeted Radiotherapy
por: Luna-Gutiérrez, Myrna, et al.
Publicado: (2023)

(177)Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer
por: Santos-Cuevas, Clara, et al.
Publicado: (2018)

Targeting CXCR4 with [(68)Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?
por: Lapa, Constantin, et al.
Publicado: (2017)

Assessing Suitability of Co@Au Core/Shell Nanoparticle Geometry for Improved Theranostics in Colon Carcinoma
por: Dhawan, Udesh, et al.
Publicado: (2021)

Design, Synthesis and Preclinical Assessment of (99m)Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging
por: Trujillo-Benítez, Diana, et al.
Publicado: (2022)

Targeted Endoradiotherapy with Lu(2)O(3)-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image
por: Luna-Gutiérrez, Myrna, et al.
Publicado: (2022)

Higher Free Triiodothyronine Is Associated With Higher HDL Particle Concentration and Smaller HDL Particle Size
por: Post, Adrian, et al.
Publicado: (2022)

Theranostic applications of multifunctional carbon nanomaterials
por: Asil, Shima Masoudi, et al.
Publicado: (2023)

(99m)Tc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans
por: Vallejo-Armenta, Paola, et al.
Publicado: (2020)

The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality
por: Cho, Kyung-Hyun
Publicado: (2022)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

HDL Cholesterol Story Is Dead: Long Live HDL!
por: Simha, Vinaya, et al.
Publicado: (2016)

Preclinical Biokinetic Modelling of Tc-99m Radiophamaceuticals Obtained from Semi-Automatic Image Processing
por: Cornejo-Aragón, Luz G., et al.
Publicado: (2017)

Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
por: Ruiz-Garcia, Henry, et al.
Publicado: (2020)

Nanoparticles for Stem Cell Therapy Bioengineering in Glioma
por: Ruiz-Garcia, Henry, et al.
Publicado: (2020)

Gold Nanorods Based Platforms for Light-Mediated Theranostics
por: Zhang, Zhenjiang, et al.
Publicado: (2013)

Virus-like nanoparticles as a theranostic platform for cancer
por: Kim, Kyeong Rok, et al.
Publicado: (2023)

Effect of HDL composition and particle size on the resistance of HDL to the oxidation
por: Shuhei, Nakanishi, et al.
Publicado: (2010)

Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality
por: Schoch, Leonie, et al.
Publicado: (2021)

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity
por: Didichenko, Svetlana A., et al.
Publicado: (2016)

Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients
por: Xia, Wenkai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4hprdbteke01ulo5r7nt7k7d9q